Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.20.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2020
Dec. 31, 2019
CURRENT ASSETS:    
Cash $ 3,551,393 $ 4,259,091
Prepaid expenses and other current assets 172,672 181,805
Current assets held for sale 197,902 375,186
Total current assets 3,921,967 4,816,082
Noncurrent assets held for sale 390,832 441,395
TOTAL ASSETS 4,312,799 5,257,477
CURRENT LIABILITIES:    
Accounts payable and accrued expenses 1,558,909 1,348,356
Current liabilities held for sale 912,472 1,040,776
Total current liabilities 2,471,381 2,389,132
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY:    
Common stock, $0.0001 par value; 100,000,000 shares authorized, 4,551,882 and 4,061,882 issued and outstanding as of March 31, 2020 and December 31, 2019, respectively 455 406
Additional paid in capital 37,612,600 37,581,914
Accumulated deficit (35,771,641) (34,713,979)
TOTAL STOCKHOLDERS' EQUITY 1,841,418 2,868,345
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 4,312,799 5,257,477
Series H Preferred Stock [Member]    
STOCKHOLDERS' EQUITY:    
Preferred stock 0 0
Series H-1 Preferred Stock [Member]    
STOCKHOLDERS' EQUITY:    
Preferred stock 0 0
Series H-2 Preferred Stock [Member]    
STOCKHOLDERS' EQUITY:    
Preferred stock 0 0
Series H-3 Preferred Stock [Member]    
STOCKHOLDERS' EQUITY:    
Preferred stock 0 0
Series H-4 Preferred Stock    
STOCKHOLDERS' EQUITY:    
Preferred stock 1 1
Series H-5 Preferred Stock    
STOCKHOLDERS' EQUITY:    
Preferred stock 0 3
Series H-6 Preferred Stock    
STOCKHOLDERS' EQUITY:    
Preferred stock $ 3 $ 0